166 related articles for article (PubMed ID: 29379553)
21. Clinical presentation and molecular identification of four uncommon alpha globin variants in Thailand. Initiation codon mutation of α2-globin Gene (HBA2:c.1delA), donor splice site mutation of α1-globin gene (IVSI-1, HBA1:c.95 + 1G>A), hemoglobin Queens Park/Chao Pra Ya (HBA1:c.98T>A) and hemoglobin Westmead (HBA2:c.369C>G).
Viprakasit V; Ekwattanakit S; Chalaow N; Riolueang S; Wijit S; Tanyut P; Chat-Uthai N; Tachavanich K
Acta Haematol; 2014; 131(2):88-94. PubMed ID: 24081251
[TBL] [Abstract][Full Text] [Related]
22. Genotype of subjects with borderline hemoglobin A2 levels: implication for beta-thalassemia carrier screening.
Galanello R; Barella S; Ideo A; Gasperini D; Rosatelli C; Paderi L; Paglietti E; Sollaino C; Perseu L; Loi D
Am J Hematol; 1994 Jun; 46(2):79-81. PubMed ID: 8172199
[TBL] [Abstract][Full Text] [Related]
23. Molecular nature of alpha-globin genes in the Saudi population.
Borgio JF
Saudi Med J; 2015 Nov; 36(11):1271-6. PubMed ID: 26593158
[TBL] [Abstract][Full Text] [Related]
24. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia.
Liu D; Zhang X; Yu L; Cai R; Ma X; Zheng C; Zhou Y; Liu Q; Wei X; Lin L; Yan T; Huang J; Mohandas N; An X; Xu X
Blood; 2014 Jul; 124(5):803-11. PubMed ID: 24829204
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation of Krüppel-like factor 1 (KLF1) and fetal hemoglobin (HbF) levels in β
Khamphikham P; Sripichai O; Munkongdee T; Fucharoen S; Tongsima S; Smith DR
Int J Hematol; 2018 Mar; 107(3):297-310. PubMed ID: 29067594
[TBL] [Abstract][Full Text] [Related]
26. [Rare thalassemia caused by novel nucleotide variants in the globin gene: four case reports and literature review].
Da ZZ; Chen LH; Jiang HM; Wang GP
Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):313-317. PubMed ID: 33979976
[No Abstract] [Full Text] [Related]
27. Pedigree Analysis of Nonhomologous Sequence Recombination of
Luo SQ; Chen XY; Tang N; Huang J; Zhong QY; Cai R; Yan TZ
Hemoglobin; 2020 Sep; 44(5):329-333. PubMed ID: 32811243
[TBL] [Abstract][Full Text] [Related]
28. Borderline hemoglobin A
Chaweephisal P; Phusua A; Fanhchaksai K; Sirichotiyakul S; Charoenkwan P
Blood Cells Mol Dis; 2019 Feb; 74():13-17. PubMed ID: 30309760
[TBL] [Abstract][Full Text] [Related]
29. Heterozygosity for the Novel
Forouzesh Pour F; Karimi K; Ghaderi Z; Tavakoli Koudehi A; Najmabadi H
Hemoglobin; 2020 Nov; 44(6):423-426. PubMed ID: 33054440
[TBL] [Abstract][Full Text] [Related]
30. Impact of iron deficiency on hemoglobin A2% in obligate β-thalassemia heterozygotes.
Sharma P; Das R; Trehan A; Bansal D; Chhabra S; Kaur J; Marwaha RK; Varma N; Garewal G
Int J Lab Hematol; 2015 Feb; 37(1):105-11. PubMed ID: 24754744
[TBL] [Abstract][Full Text] [Related]
31. Co-inheritance of alpha globin gene deletion lowering serum iron level in female beta thalassemia patients.
AbdulAzeez S; Almandil NB; Naserullah ZA; Al-Jarrash S; Al-Suliman AM; ElFakharay HI; Borgio JF
Mol Biol Rep; 2020 Jan; 47(1):603-606. PubMed ID: 31705350
[TBL] [Abstract][Full Text] [Related]
32. Challenges in prenatal diagnosis of beta thalassaemia: couples with normal HbA2 in one partner.
Gorivale M; Sawant P; Mehta P; Nadkarni A; Ghosh K; Colah R
Prenat Diagn; 2015 Dec; 35(13):1353-7. PubMed ID: 26456238
[TBL] [Abstract][Full Text] [Related]
33. Importance of Sequencing
Filser M; Gardie B; Wemeau M; Aguilar-Martinez P; Giansily-Blaizot M; Girodon F
Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052472
[TBL] [Abstract][Full Text] [Related]
34. Reference intervals for HbA
Han WP; Huang L; Li YY; Han YY; Li D; An BQ; Huang SW
Clin Biochem; 2019 Mar; 65():24-28. PubMed ID: 30503531
[TBL] [Abstract][Full Text] [Related]
35. Mutation screening of the Krüppel-like factor 1 gene using single-strand conformational polymorphism in a cohort of Iranian β-thalassemia patients.
Zaker-Kandjani B; Namdar-Aligoodarzi P; Azarkeivan A; Najmabadi H; Banan M
Hemoglobin; 2015; 39(1):24-9. PubMed ID: 25583416
[TBL] [Abstract][Full Text] [Related]
36. Delta globin gene variations leading to reduction in HbA
Hariharan P; Colaco S; Colah R; Ghosh K; Nadkarni A
Int J Lab Hematol; 2016 Dec; 38(6):610-615. PubMed ID: 27461962
[TBL] [Abstract][Full Text] [Related]
37. Compromising for carrier detection of beta thalassemia based on measurement of HbA2 levels in unusual cases.
Colaco S; Colah R; Ghosh K; Nadkarni A
Clin Chim Acta; 2012 Oct; 413(19-20):1705-7. PubMed ID: 22659060
[TBL] [Abstract][Full Text] [Related]
38. KLF1 gene mutations cause borderline HbA(2).
Perseu L; Satta S; Moi P; Demartis FR; Manunza L; Sollaino MC; Barella S; Cao A; Galanello R
Blood; 2011 Oct; 118(16):4454-8. PubMed ID: 21821711
[TBL] [Abstract][Full Text] [Related]
39. Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs.
Bhagat P; Kaur Sachdeva R; Sharma P; Updesh Singh Sachdeva M; Chhabra S; Sharma A; Das R
Infect Dis (Lond); 2016 Feb; 48(2):122-6. PubMed ID: 26431373
[TBL] [Abstract][Full Text] [Related]
40. Beta-thalassemia intermedia with exceptionally high hemoglobin A2: relationship to mutations in the beta-gene promoter.
Coleman MB; Adams JG; Plonczynski MW; Harrell AH; Walker AM; Fairbanks V; Steinberg MH
Am J Med Sci; 1992 Aug; 304(2):73-8. PubMed ID: 1380206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]